Oral steroid decreases the progression of joint destruction of large joints in the lower extremities in rheumatoid arthritis.

Medicine (Baltimore) · 2019 · PMC6882596 · PMID 31764801

Europe PMC DOI

hedged sentence

0.0587

closest p · 1.2× alpha

0.0587

boldest claim

The sentences

approached significanceP = .0587so close (0.05 < p ≤ 0.1)

The difference between patients with PSL <5 and >5 mg/day approached significance ( P = .0587), but the use of PSL was not significantly associated with the progression of joint destruction ( P = .5504).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.